Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy of Quercetin Intake in Patients With Idiopathic Pulmonary Fibrosis and Non-Idiopathic Pulmonary Fibrosis. A Two-arm, Prospective Randomized Controlled Clinical Trial.

NCT07466420 is registered in ClinicalTrials.gov with Katerina M. Antoniou as lead sponsor.

NCT NCT07466420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07466420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy of Quercetin Intake in Patients With Idiopathic Pulmonary Fibrosis and Non-Idiopathic Pulmonary Fibrosis. A Two-arm, Prospective Randomized Controlled Clinical Trial.
Lead sponsor
Katerina M. Antoniou
Phase
Not applicable
Overall status
Recruiting
Start date
January 26, 2026
Completion date
January 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrotic interstitial lungs diseases, idiopathic pulmonary fibrosis (ipf), progressive pulmonary fibrosis